MARATTO

article · Expert Opinion on Drug Metabolism & Toxicology

Pharmacogenomic and inflammatory determinants of antipsychotic-induced extrapyramidal toxicity in Egyptian patients with schizophrenia

2026Cairo University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

The ABCC2 (rs4148396) polymorphism, longer illness duration, and nonsmoking status influence risperidone-induced EPS risk in Egyptian male patients with schizophrenia.

Research topics

  • Tryptophan and brain disorders
  • Schizophrenia research and treatment
  • Pharmacological Receptor Mechanisms and Effects

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher siteRecord on OpenAlex

DOI: 10.1080/17425255.2026.2660702

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

Sign in to join the discussion

New to MARATTO™? Create a free account.